Patent · US Expired

Alpha-mercaptomethyl-benzene propanamides, pharmaceutical compositions and use

US4839358A · kind A · utility

0Cited by
2References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 23, 1988
Grant dateJun 13, 1989
Priority date
Expiry dateFeb 23, 2008

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/26
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel .alpha.-mercaptomethyl-benzene propanamides of the formula ##STR1## wherein R.sub.1 is selected from the group consisting of hydrogen and ##STR2## R.sub.1 ' is selected from the group consisting of alkyl of 1 to 5 carbon atoms and aryl optionally substituted with at least one member of the group consisting of --OH, --NO.sub.2, halogen and alkyl and alkoxy of 1 to 5 carbon atoms, X and X' are individually selected from the group consisting of hydrogen, alkyl and alkoxy of 1 to 5 carbon atoms, --OH, halogen and --CF.sub.3, R.sub.2 is selected from the group consisting of pyrrolidinyl, morpholinyl, piperidinyl, piperazinyl, tetrahydrothiazinyl and hexahydroazepinyl, all optionally substituted with at least one member of the group consisting of alkyl and alkoxy of 1 to 5 carbon atoms, --OH, --NO.sub.2, --CF.sub.3, halogen and acyl of an organic carboxylic acid of 1 to 7 carbon atoms and their non-toxic, pharmaceutically acceptable acid addition salts having analgesic activity, antidepression and anxiolytic properties.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.